PE Due Diligence: Intangible Asset Assessment
10 lessons covering intangible asset identification, valuation, and risk assessment for private equity transactions. Follow Horizon Healthcare — an £80M healthtech platform — through a complete PE due diligence.
The Due Diligence Journey
From understanding why intangible assets matter in PE to assessing regulatory risk and protecting value post-acquisition. Each lesson builds on the last, with practical scenarios using Horizon Healthcare as your worked example.
| Attribute | Detail |
|---|---|
| Company | Horizon Healthcare Ltd |
| Acquisition Price | £80M |
| Sector | Healthtech (diagnostic platform) |
| Revenue | £24M ARR |
| IP Portfolio | 4 patents, 8 trademarks, proprietary ML algorithms |
| Data Assets | 2M patient records, 5 years of outcome data |
| Regulatory | MHRA Class IIa medical device classification |
| Scenario | PE fund acquisition with £25M goodwill |
DD Risk Radar
Explore the six intangible risk categories in a PE due diligence. Watch how Horizon Healthcare's risk profile evolves as the DD progresses.
Your Lessons
10 lessons. Scroll to explore, or jump to the topic that matters most to you.
From Screening to Completion
Each lesson mirrors a stage in the PE due diligence process — starting with the investment thesis, through asset-level deep-dives, to risk analysis and regulatory compliance.
Why intangible DD matters and the structured checklist approach
Deep-dive into IP, talent, customers, and technology
Goodwill impairment risk and regulatory intangible liabilities
Integration planning and real-world case studies
DD IQ
Complete the quiz at the end of each lesson to track your DD IQ. Score 0/40
Ready to assess intangible assets in your next deal?
Use Opagio to identify, value, and monitor the intangible assets that drive PE portfolio value.